title: Malignant peripheral nerve sheath tumor invasion requires aberrantly expressed EGF receptors and is variably enhanced by multiple EGF family ligands.
abstract: Aberrant epidermal growth factor receptor (EGFR) expression promotes the pathogenesis of malignant peripheral nerve sheath tumors (MPNSTs), the most common malignancy associated with neurofibromatosis type 1, but the mechanisms by which EGFR expression promotes MPNST pathogenesis are poorly understood. We hypothesized that inappropriately expressed EGFRs promote MPNST invasion and found that these kinases are concentrated in MPNST invadopodia in vitro. Epidermal growth factor receptor knockdown inhibited the migration of unstimulated MPNST cells in vitro, and exogenous EGF further enhanced MPNST migration in a substrate-specific manner, promoting migration on laminin and, to a lesser extent, collagen. In this setting, EGF acts as a chemotactic factor. We also found that the 7 known EGFR ligands (EGF, betacellulin, epiregulin, heparin-binding EGF, transforming growth factor-α [TGF-α], amphiregulin, and epigen) variably enhanced MPNST migration in a concentration-dependent manner, with TGF-α being particularly potent. With the exception of epigen, these factors similarly promoted the migration of nonneoplastic Schwann cells. Although transcripts encoding all 7 EGFR ligands were detected in human MPNST cells and tumor tissues, only TGF-α was consistently overexpressed and was found to colocalize with EGFR in situ. These data indicate that constitutive EGFR activation, potentially driven by autocrine or paracrine TGF-α signaling, promotes the aggressive invasive behavior characteristic of MPNSTs.
authors: Department of Pathology, The University of Alabama at Birmingham, Birmingham, AL 35294, USA.
authors: Stephanie J
authors: SJ
authors: Byer
authors: Nicole M
authors: NM
authors: Brossier
authors: Lafe T
authors: LT
authors: Peavler
authors: Jenell M
authors: JM
authors: Eckert
authors: Stacey
authors: S
authors: Watkins
authors: Kevin A
authors: KA
authors: Roth
authors: Steven L
authors: SL
authors: Carroll
mesh_terms: D000818:Animals; D002478:Cells, Cultured; D066246:ErbB Receptors / Q000378:metabolism*; D055785:Gene Knockdown Techniques; D006801:Humans; D015151:Immunoblotting; D007150:Immunohistochemistry; D008024:Ligands; D009361:Neoplasm Invasiveness / Q000473:pathology*; D018317:Nerve Sheath Neoplasms / Q000378:metabolism* / Q000473:pathology; D051381:Rats; D060888:Real-Time Polymerase Chain Reaction; D012583:Schwann Cells; D015398:Signal Transduction / Q000502:physiology*; D016211:Transforming Growth Factor alpha / Q000378:metabolism
chemical_list: D008024:Ligands; D016211:Transforming Growth Factor alpha; D066246:ErbB Receptors
references: Cancer Res. 2011 Jul 1;71(13):4686-95
references: 21551250
references: Cancer Cell. 2005 Jan;7(1):65-75
references: 15652750
references: Cancer. 1986 May 15;57(10):2006-21
references: 3082508
references: Mol Neurobiol. 1997 Feb-Apr;14(1-2):67-116
references: 9170101
references: Oncogene. 2005 Aug 25;24(36):5589-605
references: 15897877
references: J Neurooncol. 2009 Sep;94(3):383-8
references: 19330289
references: J Neuropathol Exp Neurol. 2003 May;62(5):520-9
references: 12769191
references: Glia. 2003 Aug;43(2):104-18
references: 12838503
references: Cancer Res. 2002 Mar 1;62(5):1573-7
references: 11894862
references: J Clin Invest. 2000 May;105(9):1233-41
references: 10791998
references: Curr Opin Neurol. 2002 Dec;15(6):679-84
references: 12447105
references: Cancer Res. 2002 Aug 1;62(15):4507-13
references: 12154062
references: J Med Genet. 2007 Jul;44(7):463-6
references: 17327286
references: Cell Motil Cytoskeleton. 1999;42(4):331-43
references: 10223638
references: Nat Rev Mol Cell Biol. 2004 Aug;5(8):647-57
references: 15366708
references: Cancer Cell. 2008 Feb;13(2):117-28
references: 18242512
references: Clin Exp Metastasis. 1995 Jul;13(4):303-14
references: 7606893
references: J Anat. 2006 May;208(5):595-9
references: 16637882
references: Glia. 2009 Nov 1;57(14):1501-20
references: 19306381
references: Oncogene. 2007 Oct 4;26(45):6469-87
references: 17471238
references: Neuro Oncol. 2011 Jan;13(1):28-41
references: 21075781
references: Am J Pathol. 2006 May;168(5):1686-96
references: 16651634
references: Neuro Oncol. 2008 Dec;10(6):946-57
references: 18650488
references: Virchows Arch A Pathol Anat Histopathol. 1992;421(4):331-8
references: 1413494
references: Cancer Cell. 2008 Feb;13(2):105-16
references: 18242511
references: Proc Natl Acad Sci U S A. 2006 Sep 12;103(37):13759-64
references: 16945906
references: J Neuropathol Exp Neurol. 2002 Aug;61(8):702-9
references: 12152785
references: J Cell Biol. 1983 Sep;97(3):772-7
references: 6885918
references: J Med Genet. 2002 May;39(5):311-4
references: 12011145
references: J Clin Oncol. 2005 Nov 20;23(33):8422-30
references: 16293873
references: J Neuropathol Exp Neurol. 2006 Feb;65(2):162-75
references: 16462207